Le Lézard
Classified in: Covid-19 virus
Subjects: MAV, CPG

The Québec Ombudsman's Progress Report: COVID-19 in CHSLDs during the first wave of the pandemic - Media invitation -


QUÉBEC CITY, Dec. 3, 2020 /CNW Telbec/ - Ombudsperson Marie Rinfret invites media representatives to a virtual press conference to be held on Thursday, December 10, 2020, at 11 a.m., when she will present her Progress Report concerning the ongoing systemic investigation into COVID-19 in residential and long-term care centres (CHSLDs) during the first wave of the pandemic.

This virtual press conference will take place:

           ------------------------------------------------------------------------------------------------------------

DATE: Thursday, December 10, 2020

TIME: 11 a.m.

Please click on the following link at around 10:55 a.m.: https://bit.ly/39kC4T9

           --------------------------------------------------------------------------------------------------------------

Please confirm attendance with Carole-Anne Huot by email at
[email protected].

IMPORTANT NOTE:
The Progress Report will be released on December 10, 2020 at 10 a.m. on the Québec Ombudsman's website so that the media representatives can become familiar with the document ahead of the press conference.

The press conference will be available via the following link: https://bit.ly/39kC4T9

During the press conference, make sure to turn off the camera and microphone on your computer.

For the question period, you will have to raise your hand and we will give you the floor one by one. We ask that participants identify themselves and the media outlet they represent.

Use of one of the following updated search engines is recommended:

PC: Chrome or Edge
Apple: Safari or Mozilla

Please note that the platform that will be used for the press conference does not support Explorer 11.

SOURCE Protecteur du citoyen


These press releases may also interest you

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 17:50
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

at 17:30
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

at 17:10
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

at 17:00
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...



News published on and distributed by: